
Onco'Zine - Network
@oncozine
Onco’Zine reports about current research and development in hematology and oncology.
ID: 71468093
http://www.oncozine.com 04-09-2009 06:01:15
5,5K Tweet
717 Followers
607 Following

Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in Patients with Early-stage Classical Hodgkin Lymphoma oncozine.com/brentuximab-ve… #ADC International Conference on Malignant Lymphoma #17ICML @SeagenGlobal Takeda Oncology ADC Review #lymphoma #oncology #hematology

Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in Patients with Early-stage Classical Hodgkin Lymphoma oncozine.com/brentuximab-ve… #ADC International Conference on Malignant Lymphoma #17ICML @SeagenGlobal Takeda Oncology ADC Review #lymphoma #oncology #hematology

Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in Patients with Early-stage Classical Hodgkin Lymphoma oncozine.com/brentuximab-ve… #ADC International Conference on Malignant Lymphoma #17ICML @SeagenGlobal Takeda Oncology ADC Review #lymphoma #oncology #hematology


Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in Patients with Early-stage Classical Hodgkin Lymphoma oncozine.com/brentuximab-ve… #ADC International Conference on Malignant Lymphoma #17ICML @SeagenGlobal Takeda Oncology ADC Review #lymphoma #oncology #hematology

Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in Patients with Early-stage Classical Hodgkin Lymphoma oncozine.com/brentuximab-ve… #ADC International Conference on Malignant Lymphoma #17ICML @SeagenGlobal Takeda Oncology ADC Review #lymphoma #oncology #hematology

Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in Patients with Early-stage Classical Hodgkin Lymphoma oncozine.com/brentuximab-ve… #ADC International Conference on Malignant Lymphoma #17ICML @SeagenGlobal Takeda Oncology ADC Review #lymphoma #oncology #hematology


Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in Patients with Early-stage Classical Hodgkin Lymphoma oncozine.com/brentuximab-ve… #ADC International Conference on Malignant Lymphoma #17ICML @SeagenGlobal Takeda Oncology ADC Review #lymphoma #oncology #hematology

The Onco'Zine - Network Brief with Peter Hofland on UK Health Radio™ - Dr. Heery MD, medical oncologist with expertise in the translational & clinical development of #immunotherapies & Dr. Verstovsek about the developments in treatment of myeloproliferative neoplasm. bit.ly/3K9XFzF


What is #SonodynamicTherapy & how is it designed to treat aggressive brain cancers like #glioblastoma & #DIPG? Learn more about this technology from our CMO Dr. Ely Benaim in Onco'Zine - Network: oncozine.com/sonodynamic-th…



Our CMO Dr. Ely Benaim entered the scene at Onco'Zine - Network to discuss #SonodynamicTherapy & the impact it may have on the future of treating deadly brain tumors such as #glioblastoma & #DIPG. Check it out here to learn more about the tech & our clinical trials: oncozine.com/sonodynamic-th…





